[HTML][HTML] Brain metastasis treatment: the place of tyrosine kinase inhibitors and how to facilitate their diffusion across the blood–brain barrier

E Angeli, G Bousquet - Pharmaceutics, 2021 - mdpi.com
… , lung cancer, and breast cancer brain metastases. We also … brain metastases and die
because of the limited efficacy of … in the brain metastases, suggesting a direct inhibitory effect of …

Tyrosine kinase inhibitor therapy for brain metastases in non-small-cell lung cancer: a primer for radiologists

C Dodson, TJ Richards, DA Smith… - American Journal of …, 2020 - Am Soc Neuroradiology
… have been developed that demonstrate efficacy in non-small-cell lung cancer (NSCLC) …
. Tyrosine kinase inhibitors show different anti-brain metastases efficacy in NSCLC: a direct

Efficacy and safety of EGFR-TKI combined with WBRT vs. WBRT alone in the treatment of brain metastases from NSCLC: a systematic review and meta-analysis

S Li, S Xu, L Li, Z Xue, L He - Frontiers in Neurology, 2024 - frontiersin.org
… anti-tumoral efficacy of radiotherapy can be enhanced through the incorporation of epidermal
growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). These inhibitors possess the …

The impact of anlotinib on brain metastases of non‐small cell lung cancer: Post hoc analysis of a phase III randomized control trial (ALTER0303)

S Jiang, H Liang, Z Liu, S Zhao, J Liu, Z Xie… - The …, 2020 - academic.oup.com
… trials have demonstrated that tyrosine kinase inhibitors (TKIs; eg… of antibrain metastatic
tumor effect of multitargeted agents. … the potential efficacy of multitargeted inhibitor for BM in …

Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo

Z Liu, N Shah, KL Marshall, SA Sprowls, P Saralkar… - Archives of …, 2021 - Springer
lung cancer brain metastasis (LCBM), exhibited not only resistance to epidermal growth factor
receptor-tyrosine kinase inhibitor (… and AZD9291 showed comparable efficiency in treating …

[HTML][HTML] Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology …

E Carcereny, A Fernández-Nistal, A López, C Montoto… - Oncotarget, 2021 - ncbi.nlm.nih.gov
… conclude that brigatinib shows a predicted efficacy similar to … Thus far, three generations
of ALK tyrosine kinase inhibitors (… ALK+ NSCLC patients [37–39], but no direct comparison …

[HTML][HTML] Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs

A Butle, A Joshi, V Noronha, K Prabhash, A Dutt - Translational Oncology, 2021 - Elsevier
tyrosine kinase inhibitor (TKI), to the first-generation TKI erlotinib along with their daily vs
weekly dosing efficacy… of the homing of EGFR mutant lung cancer cells to the lungs of the mice …

Efficacy and mechanism study of cordycepin against brain metastases of small cell lung cancer based on zebrafish

SR Zhang, M Pan, YB Gao, RY Fan, XN Bin, ST Qian… - Phytomedicine, 2023 - Elsevier
… as well as other chemotherapy drugs all showed good anti-BM … by soaking and could
directly enter the brain without going … has shown better anti-brain metastasis activity than other

[HTML][HTML] Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer

H Lu, T Chen, Y Wang, Y He, Z Pang, Y Wang - Scientific Reports, 2022 - nature.com
… neck cancer, and non-small cell lung cancer 4 . However, HER-2-… As a tyrosine kinase
inhibitor that targets both epidermal … and lapatinib, the anti-brain metastases efficacy of Ang-MIC …

Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases

KE Blethen, TA Arsiwala, RA Fladeland… - Neuro-Oncology …, 2021 - academic.oup.com
Direct effects of radiation include a decrease in tight junction … Sorafenib, a tyrosine kinase
inhibitor, in the presence of … Enhanced anti-brain metastasis from non-small cell lung cancer of …